| | 114870-03-0 Basic information More.. |
| Product Name: | Fondaparinux sodium | | Synonyms: | Methyl O-2-Deoxy-6-O-sulfo-2-(sulfoaMino)-α-D-glucopyranosyl-(14)-O-β-
D-glucopyranuronosyl-(14)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoaMino)-α-D-glucopyranosyl-(14)-O-2-O-sulfo-α-L-idopyranuronosyl-(14)-2-deoxy-2-(sulfoaMino)-α-D-glucopyranoside 6-(Hydrogen Sulfate) DecasodiuM Salt;Fondaparinux SodiuM Identification;Fondaparinux sodium N-4;Fondaparinux sodium, >=98%;decasodium (2R,3S,4S,5R,6R)-3-[(2R,3R,4R,6R)-5-[(2R,3R,4S,5S,6S)-6-carboxylato-5-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-(sulfonatooxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-oxan-2-yl]oxy-3-(sulfonatoamino)-4-sulfonatooxy-6-(sulfonatooxymethyl)oxan-2-yl]oxy-4-hydroxy-6-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxy-5-sulfonatooxy-oxane-2-carboxylate;Fondaparinux sodium;Arixtra (tn);D01844 | | CAS: | 114870-03-0 | | MF: | C31H43N3O49S8.10Na | | MW: | 1728.08 | | EINECS: | 686-283-7 | | Mol File: | 114870-03-0.mol |  |
Use
Fondaparinux sodium was first introduced in the us for prophylaxis of deep vein thrombosis which may lead to pulmonary embolism following major orthopaedic surgery. fondaparinux is the first of a new class of antithrombic agents distinct from low molecular weight heparin (lmwh) and heparin. this entirely synthetic molecule is a copy of the heparin pentasaccharide sequence, the shortest fragment able to catalyze antithrombin lllmediated inhibition of factor xa thereby inhibiting thrombin generation without antithrombin action.
- Fondaparinux Sodium
-
- US $0.00-0.00 / Kg/Bag
- 2024-05-08
- CAS:114870-03-0
- Min. Order: 1Kg/Bag
- Purity: 99% up, High Density
- Supply Ability: 20 tons
- Fondaparinux sodium
-
- US $0.00 / gram
- 2024-03-15
- CAS:114870-03-0
- Min. Order: 1gram
- Purity: 99%
- Supply Ability: 1tons
- Fondaparinux Sodium
-
- US $0.00 / g
- 2024-02-06
- CAS:114870-03-0
- Min. Order: 1g
- Purity: 99.99%HPLC
- Supply Ability: 200kg
|
|
114870-03-0
Recommend Suppliers |
|